Detalhe da pesquisa
1.
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance.
Nature
; 623(7989): 1053-1061, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844613
2.
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.
Clin Cancer Res
; 28(21): 4634-4641, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984704
3.
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717027
4.
Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers.
Cancer Discov
; 11(1): 92-107, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958578
5.
Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.
Inflamm Bowel Dis
; 24(7): 1503-1509, 2018 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29762666